19 June 2013
Keywords: astrazenca, ends, its, deal, artherogenics, anglo-swedish, drug
Article | 30 April 2007
Anglo-Swedish drug major AstraZeneca says that it has terminated its collaboration with US drugmaker AtheroGenics after the drug they were
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 April 2007
© 2013 thepharmaletter.com